PharmaBXL
De berekende faillissementskans van PharmaBXL over 12 maanden bedraagt 1,7% (gemiddeld). Het bedrijf is actief sinds 2022 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 3 jaar |
| Bestuur | 2 |
| Vestigingen | 1 |
| Publicaties | 7 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2024 | micro | 30-09-2025 | 2025-00526921 |
| 31-12-2023 | verkort | 26-08-2024 | 2024-00372308 |
-
PharmaLegalRechtspersoonGedelegeerd bestuurder· vast vert.: Georges DE FEUStaatsblad-akte 26044294 (31-03-2026)Actief13-02-2026 → heden
-
Actief06-02-2023 → heden
Voormalige bestuurders (1)
-
O2CRechtspersoonGedelegeerd bestuurder· vast vert.: Olivier OLBRECHTSStaatsblad-akte 26044294 (31-03-2026)Voormalig- → 13-02-2026
| NACE primair | 82990 |
| Rechtsvorm | BV(610) |
| Oprichtingsdatum | 29-12-2022 |
| Status | Actief |
| Postcode | 1000 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 21803C0405/00H000 | Brussel | 211 m² | 1 · 172 m² | 22,4 m · 6 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
13-04-2026 Act object · General meeting · Permanent representative · Officer resignation
- Filing: 2026-04-03 · PharmaPROP.BXL
- Publication: 2026-04-13 · PharmaPROP.BXL
- Act object: Constatation changement représentant permanent · PharmaPROP.BXL
- General meeting: 2026-02-13 · PharmaPROP.BXL
- Permanent representative: role: représentant permanent, context: représentation de la société-administrateur PharmaBXL au sein de PharmaPROP.BXL, start_date: 2025-12-12 · Georges DE FEU
- Officer resignation: role: représentant permanent, context: remplacement par Georges DE FEU, end_date: 2025-12-12 · Olivier OLBRECHTS
- Approval: meeting_date: 2026-02-13, decision_date: 2025-12-12, approving_body: organe d'administration de la SRL PharmaBXL, approved_by_meeting: assemblée générale spéciale de PharmaPROP.BXL · PharmaPROP.BXL
Technische details
{
"facts": [
{
"type": "filing",
"quote": "D\u00E9pos\u00E9 / Re\u00E7u le U 3 AVR. 2026",
"value": "2026-04-03",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 13/04/2026",
"value": "2026-04-13",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Constatation changement repr\u00E9sentant permanent",
"value": "Constatation changement repr\u00E9sentant permanent",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Extrait du proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale sp\u00E9ciale tenue le 13/02/2026",
"value": "2026-02-13",
"object": null,
"subject": "e1"
},
{
"type": "permanent_representative",
"quote": "L\u0027assembl\u00E9e constate que la soci\u00E9t\u00E9-administrateur, SRL \u00AB PharmaBXL \u003E (num\u00E9ro d\u0027entreprise 0795.508.480), est repr\u00E9sent\u00E9e par Monsieur Georges DE FEU en qualit\u00E9 de repr\u00E9sentant permanent, \u00E0 compter du 12/12/2025",
"value": {
"role": "repr\u00E9sentant permanent",
"context": "repr\u00E9sentation de la soci\u00E9t\u00E9-administrateur PharmaBXL au sein de PharmaPROP.BXL",
"start_date": "2025-12-12"
},
"object": "e2",
"subject": "e3"
},
{
"type": "officer_resignation",
"quote": "et non plus par Monsieur Olivier OLBRECHTS.",
"value": {
"role": "repr\u00E9sentant permanent",
"context": "remplacement par Georges DE FEU",
"end_date": "2025-12-12"
},
"object": "e2",
"subject": "e4"
},
{
"type": "approval",
"quote": "L\u0027assembl\u00E9e prend acte de la d\u00E9cision prise le 12/12/2025 par l\u0027organe d\u0027administration de la SRL \u003C\u003C PharmaBXL \u00BB (num\u00E9ro d\u0027entreprise 0795.508.480), qui est soci\u00E9t\u00E9-administrateur de notre soci\u00E9t\u00E9.",
"value": {
"meeting_date": "2026-02-13",
"decision_date": "2025-12-12",
"approving_body": "organe d\u0027administration de la SRL PharmaBXL",
"approved_by_meeting": "assembl\u00E9e g\u00E9n\u00E9rale sp\u00E9ciale de PharmaPROP.BXL"
},
"object": "e2",
"subject": "e1"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1529,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0804.643.803",
"kind": "company",
"name": "PharmaPROP.BXL",
"attrs": {
"address": "Avenue Albert 154, 1190 Forest",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e2",
"kbo": "0795.508.480",
"kind": "company",
"name": "PharmaBXL",
"attrs": {
"role": "soci\u00E9t\u00E9-administrateur",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Georges DE FEU",
"attrs": {
"role": "repr\u00E9sentant permanent"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Olivier OLBRECHTS",
"attrs": {
"role": "ancien repr\u00E9sentant permanent"
}
}
]
}13-04-2026 Act object · General meeting · Officer resignation · Officer discharge
- Filing: 2026-04-03 · PharmaOPS.BXL
- Publication: 2026-04-13 · PharmaOPS.BXL
- Act object: Démission administrateur - Constatation changement représentant permanent · PharmaOPS.BXL
- General meeting: 2026-02-13 · PharmaOPS.BXL
- Officer resignation: role: administrateur, effective_date: 2025-12-12 · Georges DE FEU
- Officer discharge · Georges DE FEU
- Permanent representative: role: représentant permanent, for_company: PharmaOPS.BXL, effective_date: 2025-12-12 · Georges DE FEU
- Permanent representative: role: représentant permanent, status: ceased, for_company: PharmaOPS.BXL, effective_date: 2025-12-12 · Olivier OLBRECHTS
Technische details
{
"facts": [
{
"type": "filing",
"quote": "U 3 AVR. 2026",
"value": "2026-04-03",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "13/04/2026",
"value": "2026-04-13",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: D\u00E9mission administrateur - Constatation changement repr\u00E9sentant permanent",
"value": "D\u00E9mission administrateur - Constatation changement repr\u00E9sentant permanent",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Extrait du proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale sp\u00E9ciale tenue le 13/02/2026",
"value": "2026-02-13",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "L\u0027assembl\u00E9e a pris acte de la d\u00E9mission en tant qu\u0027administrateur, offerte volontairement avec effet au 12/12/2025, par Monsieur Georges DE FEU.",
"value": {
"role": "administrateur",
"effective_date": "2025-12-12"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_discharge",
"quote": "L\u0027approbation des comptes annuels de l\u0027exercice \u00E9coul\u00E9 vaudra d\u00E9charge pour l\u0027exercice de son mandat.",
"value": null,
"object": "e1",
"subject": "e2"
},
{
"type": "permanent_representative",
"quote": "L\u0027assembl\u00E9e constate que la soci\u00E9t\u00E9-administrateur, SRL \u003C PharmaBXL \u00BB (num\u00E9ro d\u0027entreprise 0795.508.480), est repr\u00E9sent\u00E9e par Monsieur Georges DE FEU en qualit\u00E9 de repr\u00E9sentant permanent, \u00E0 compter du 12/12/2025, pour l\u0027exercice de son mandat d\u0027administration au sein de notre soci\u00E9t\u00E9 (SRL \u003C PharmaOPS.BXL \u003E)",
"value": {
"role": "repr\u00E9sentant permanent",
"for_company": "PharmaOPS.BXL",
"effective_date": "2025-12-12"
},
"object": "e3",
"subject": "e2"
},
{
"type": "permanent_representative",
"quote": "et non plus par Monsieur Olivier OLBRECHTS.",
"value": {
"role": "repr\u00E9sentant permanent",
"status": "ceased",
"for_company": "PharmaOPS.BXL",
"effective_date": "2025-12-12"
},
"object": "e3",
"subject": "e4"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1967,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0804.644.494",
"kind": "company",
"name": "PharmaOPS.BXL",
"attrs": {
"seat": "Avenue Albert 154, 1190 Forest",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Georges DE FEU",
"attrs": {}
},
{
"id": "e3",
"kbo": "0795.508.480",
"kind": "company",
"name": "PharmaBXL",
"attrs": {
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Olivier OLBRECHTS",
"attrs": {}
}
]
}31-03-2026 Act object · Board meeting · Officer resignation · Officer appointment
- Filing: 2026-03-24 · PharmaBXL
- Act object: Ontslag en benoeming gedelegeerd bestuurder · PharmaBXL
- Board meeting: 2026-02-13 · PharmaBXL
- Officer resignation: role: gedelegeerd bestuurder, effective_date: 2026-02-13 · O2C
- Officer appointment: role: gedelegeerd bestuurder, duration: onbepaalde duur, effective_date: 2026-02-13 · PharmaLegal
- Publication: 2026-03-31
Technische details
{
"facts": [
{
"type": "filing",
"quote": "24 MAART 2026 ter griffie van de Nederlandstalige ondernemingsrechtbank Brussel",
"value": "2026-03-24",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Onderwerp akte: Ontslag en benoeming gedelegeerd bestuurder",
"value": "Ontslag en benoeming gedelegeerd bestuurder",
"object": null,
"subject": "e1"
},
{
"type": "board_meeting",
"quote": "Uittreksel uit de notulen van de vergadering van de raad van bestuur gehouden op 13/02/2026:",
"value": "2026-02-13",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "De raad van bestuur besluit om de besloten vennootschap \u0022O2C\u0022 (ondernemingsnummer 0844.823.280), vast vertegenwoordigd door de heer Olivier OLBRECHTS, met ingang van heden te ontslaan als gedelegeerd bestuurder.",
"value": {
"role": "gedelegeerd bestuurder",
"effective_date": "2026-02-13"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_appointment",
"quote": "Vervolgens besluit de raad van bestuur om - overeenkomstig artikel 11 \u00A71 van de statuten - het dagelijks bestuur van de vennootschap te delegeren aan de volgende bestuurder, die bijgevolg wordt aangesteld als gedelegeerd bestuurder: De besloten vennootschap \u0022PharmaLegal\u0022... Dit mandaat neemt ingang op heden en wordt toegekend voor onbepaalde duur.",
"value": {
"role": "gedelegeerd bestuurder",
"duration": "onbepaalde duur",
"effective_date": "2026-02-13"
},
"object": "e1",
"subject": "e4"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 31/03/2026",
"value": "2026-03-31",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1850,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0795.508.480",
"kind": "company",
"name": "PharmaBXL",
"attrs": {
"seat": "Koekelberglaan 1, 1082 Sint-Agatha-Berchem",
"legal_form": "Besloten vennootschap"
}
},
{
"id": "e2",
"kbo": "0844.823.280",
"kind": "company",
"name": "O2C",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Olivier OLBRECHTS",
"attrs": {
"role": "vast vertegenwoordiger van O2C"
}
},
{
"id": "e4",
"kbo": "0541.432.719",
"kind": "company",
"name": "PharmaLegal",
"attrs": {
"rpr": "RPR Brussel (Nederlandstalige afdeling)",
"seat": "Besmelaan 103, 1190 Vorst",
"legal_form": "Besloten vennootschap"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Georges DE FEU",
"attrs": {
"role": "vaste vertegenwoordiger van PharmaLegal"
}
}
]
}26-01-2026 Statutenwijziging, vertaling van de statuten, coördinatie van de statuten en aanpassing van specifieke artikelen
Technische details
{
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2026-01-26",
"filing_date": "2026-01-22",
"act_kind_objet": "ONTSLAGEN, BENOEMINGEN, KAPITAAL, AANDELEN, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-12-30",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"targeted_amendment"
],
"scope": "full_restatement",
"trigger": "other",
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": {
"firm_kbo": null,
"firm_name": "Be Audit",
"ibr_number": null,
"individual_name": "Ghislain DOCHEN"
},
"subject_company": {
"kbo": "0795.508.480",
"name_full_after": "PharmaBXL",
"legal_form_after": "BESloten Vennootschap",
"name_full_before": "PharmaBXL",
"current_zetel_raw": "Koekelberglaan 1, 1082 Sint-Agatha-Berchem",
"legal_form_before": "BESloten Vennootschap"
},
"special_mandates": [
{
"holder_kbo": "0544.887.107",
"holder_name": "Cercatrova",
"scope_categories": [
"kbo"
],
"with_substitution": true
},
{
"holder_kbo": null,
"holder_name": "REMEDIA",
"scope_categories": [
"kbo"
],
"with_substitution": true
},
{
"holder_kbo": "0812.730.336",
"holder_name": "DRI3M",
"scope_categories": [
"kbo"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Artikel 5 van de statuten is vervangen door nieuwe tekst die de uitgifte van nieuwe aandelen regelt, de winstverdeling en het boekhoudkundige verkeer van inbrengen in natura en in geld.",
"new_text": "Als vergoeding voor de inbrengen werden zes miljoen achthonderd negentwintig duizend honderd tachtig (6.829.180) uitgegeven. Ieder aandeel geeft een gelijk recht in de winstverdeling en in het vereffeningssaldo. De huidige inbrengen werden geboekt op een beschikbare eigen vermogensrekening. Voor de latere inbrengen zullen de uitgiftevoorwaarden bepalen of zij geboekt worden op een onbeschikbare da",
"change_kind": "replaced",
"article_title": null,
"article_number": "5"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"drie volmachten",
"een aanwezigheidslijst",
"de geco\u00F6rdineerde tekst van statuten",
"het verslag van het bestuursorgaan opgesteld in toepassing van de artikelen 5:121, \u00A71, eerste lid, 5:130 en 5:133, \u00A71, eerste lid van het Wetboek van vennootschappen en verenigingen",
"het verslag van de bedrijfsrevisor opgesteld in toepassing van artikel 5:133, \u00A71, tweede lid van het Wetboek van vennootschappen en verenigingen",
"het verslag van de bedrijfsrevisor opgesteld in toepassing van artikel 5:121, \u00A71, tweede lid en artikel 5:130 van het Wetboek van vennootschappen en verenigingen"
],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": null,
"voorkeurrecht_rules_changed": true,
"aandelenoverdracht_restrictions_changed": false
},
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"eigen_aandelen_inkoop",
"wvv_capital_release",
"share_class_creation"
],
"split_ratio": null,
"shares_after": null,
"shares_before": null,
"capital_after_eur": null,
"capital_before_eur": null,
"share_classes_after": [
{
"count": null,
"label": "bestaande aandelen",
"rights_summary": "gelijk recht in de winstverdeling en in het vereffeningssaldo",
"voting_per_share": null
},
{
"count": null,
"label": "nieuwe aandelen",
"rights_summary": "gelijk recht in de winstverdeling en in het vereffeningssaldo",
"voting_per_share": null
}
]
},
"coordinated_text_lineage": null
}14-03-2023 Jo Ravelingien benoemd tot bestuurder
- Jo Ravelingien, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jo Ravelingien",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0894633869",
"name": "Remedia",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-02-06",
"evidence_quote": "Tijdens de bijzondere algemene vergadering gehouden op het adres van de statutaire zetel op 06/02/2023 werd besloten te benoemen als bestuurder, de commanditaire vennootschap Remedia, met zetel te 1861 Meise, Brussegemsesteenweg 39, met als ondernemingsnummer 0894.633.869, vast vertegenwoordigd door"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0795.508.480",
"name_full": "PHARMABXL",
"legal_form": "BV"
}
}01-02-2023 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2023-01-26",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0795.508.480",
"name_full": "PHARMABXL",
"legal_form": "BV"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}02-01-2023 Oprichting van een BV
Technische details
{
"kind": "oprichting",
"seat": "1082 Sint-Agatha-Berchem, Koekelberglaan 1",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1971-08-10",
"name": "BRACKE Sven Guido Diane",
"niss": null,
"address": "1780 Wemmel, de Limburg Stirumlaan 81"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 6222.2,
"holder_person_name": "BRACKE Sven Guido Diane",
"is_subscriber_only": true,
"n_shares_subscribed": 62222,
"amount_subscribed_eur": 6222.2,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1989-07-02",
"name": "DE FEU Georges Charlotte Jan Madelaine",
"niss": null,
"address": "1060 Sint-Gillis, Bosquetstraat 50 bus 0003"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 50222.2,
"holder_person_name": "DE FEU Georges Charlotte Jan Madelaine",
"is_subscriber_only": false,
"n_shares_subscribed": 502222,
"amount_subscribed_eur": 50222.2,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1973-10-25",
"name": "GILIAS Filip Maria Andre",
"niss": null,
"address": "3384 Glabbeek (Attenrode), Doemstraat 6"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 12444.4,
"holder_person_name": "GILIAS Filip Maria Andre",
"is_subscriber_only": false,
"n_shares_subscribed": 124444,
"amount_subscribed_eur": 12444.4,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1975-01-21",
"name": "OLBRECHTS Olivier Ivan Val\u00E9ry",
"niss": null,
"address": "1180 Ukkel, Prins van Oranjelaan 50"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 24888.9,
"holder_person_name": "OLBRECHTS Olivier Ivan Val\u00E9ry",
"is_subscriber_only": false,
"n_shares_subscribed": 248889,
"amount_subscribed_eur": 24888.9,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1996-10-16",
"name": "VANDENHOVE Thibault Henri Brigitte",
"niss": null,
"address": "1060 Sint-Gillis, Blanchestraat 37 GV"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 3111.1,
"holder_person_name": "VANDENHOVE Thibault Henri Brigitte",
"is_subscriber_only": true,
"n_shares_subscribed": 31111,
"amount_subscribed_eur": 3111.1,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1988-11-06",
"name": "VAN HAVERBEKE Charles Daniel Jozef Petrus",
"niss": null,
"address": "2000 Antwerpen, Kammenstraat 68 bus 301"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 3111.1,
"holder_person_name": "VAN HAVERBEKE Charles Daniel Jozef Petrus",
"is_subscriber_only": false,
"n_shares_subscribed": 31111,
"amount_subscribed_eur": 3111.1,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 10000,
"subject_company": {
"kbo": "0795.508.480",
"name_full": "PharmaBXL",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2022-12-28",
"post_incorporation_mandates": []
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamNL | PharmaBXL |